[1] Parameswaran N, Hall CS, Bomberger JM, et al.Nega-tive growth effects of ciglitazone on kidney interstitial fibro-blasts:role of PPAR-gamma[J] .Kidney Blood Press Res, 2003, 26(1) :2-9. [2] Tsuchiya T, Shimizu H, Shimomura K, et al.Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells[J] .Am J Nephrol, 2003, 23(4) :222-228. [3] Koya D, Haneda M, Nakagawa H, et al.Amelioration of accelerated diabetic mesangial expansion by treatmentwith a PKC beta inhibitor in diabetic db db mice, a rodent model for type 2 diabetes[J] .FASEB J, 2000, 14(3) :439-447. [4] Park IS, Kiyomoto H, Abboud SL, et al.Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes[J] .Diabetes, 1997,46(3) :473-480. [5] Border WA, Noble NA.Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy[J] .Kidney Int, 1998, 54(4) :1390-1391. [6] Yamashita H, Nagai Y, Takamura T, et al.Thiazolidine-dione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat[J] .Me-tabolism, 2002, 51(4) :403-408. [7] McCarthy KJ, Routh RE, Shaw W, et al. Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expression[J] .Kidney Int, 2000, 58(6) :2341-2350. [8] Bakris G, Viberti G, Weston WM, et al.Rosiglitazone reduces urinary albumin excretion in type 2 diabetes[J] .J Hum Hypertens, 2003, 17(1) :7-12. [9] Zafiriou S, Stanners SR, Saad S, et al.Pioglitazone in-hibits cell growth and reduces matrix production in human kidney fibroblasts[J] .J Am Soc Nephrol, 2005, 16(3) :638-645 |